Acid Sphingomyelinase deficiency (ASMD)
RareMetabolic
Acid Sphingomyelinase deficiency (ASMD) is treated with 1 medication in our database, including XENPOZYME. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Sanofi. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Acid Sphingomyelinase deficiency (ASMD) treatment below.
What help exists for Acid Sphingomyelinase deficiency (ASMD)
1
drugs indexed
1
with copay cards
1
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Acid Sphingomyelinase deficiency (ASMD)
1 total🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Acid Sphingomyelinase deficiency (ASMD) drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Grants for Acid Sphingomyelinase deficiency (ASMD) patients
2 total · 0 openAcid Sphingomyelinase deficiency (ASMD) is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →